Regulation of keratinocyte growth factor gene expression by interleukin 1 - PubMed (original) (raw)
. 1994 Apr 8;269(14):10753-7.
Affiliations
- PMID: 7511604
Free article
Regulation of keratinocyte growth factor gene expression by interleukin 1
M Chedid et al. J Biol Chem. 1994.
Free article
Abstract
Keratinocyte growth factor (KGF) is a stromally derived member of the fibroblast growth factor family (FGF7) with potent mitogenic activity on a variety of epithelial cells. To identify molecules that regulate the expression of this paracrine mediator of epithelial proliferation, we investigated the effects of various cytokines and growth factors on KGF production by fibroblasts. The proinflammatory cytokine interleukin 1 (IL1) strongly induced the expression of KGF RNA in fibroblasts from multiple sources. Platelet-derived growth factor BB, IL6, and transforming growth factor alpha caused a moderate elevation, while tumor necrosis factor alpha and basic FGF did not alter the level of KGF RNA expression. The induction by IL1 of KGF transcript levels was time and dose dependent and specifically blocked by anti-IL1 antibodies. Nuclear run on experiments indicated that IL1 stimulated KGF gene transcription. Western blot analysis and keratinocyte proliferation assays demonstrated a corresponding increase in mitogenically active KGF protein in conditioned medium obtained from IL1-treated fibroblasts. The stimulation of KGF expression by IL1 and other cytokines such as IL6, transforming growth factor alpha, and platelet-derived growth factor may provide a mechanism for KGF induction during inflammation that would support its proposed role as mediator of reepithelialization and wound healing.
Similar articles
- Regulation of keratinocyte growth factor gene expression in human skin fibroblasts.
Tang A, Gilchrest BA. Tang A, et al. J Dermatol Sci. 1996 Jan;11(1):41-50. doi: 10.1016/0923-1811(95)00418-1. J Dermatol Sci. 1996. PMID: 8867766 - Glucocorticoids inhibit keratinocyte growth factor production in primary dermal fibroblasts.
Chedid M, Hoyle JR, Csaky KG, Rubin JS. Chedid M, et al. Endocrinology. 1996 Jun;137(6):2232-7. doi: 10.1210/endo.137.6.8641170. Endocrinology. 1996. PMID: 8641170 - Keratinocyte growth factor as a cytokine that mediates mesenchymal-epithelial interaction.
Rubin JS, Bottaro DP, Chedid M, Miki T, Ron D, Cunha GR, Finch PW. Rubin JS, et al. EXS. 1995;74:191-214. doi: 10.1007/978-3-0348-9070-0_10. EXS. 1995. PMID: 8527895 Review. - Keratinocyte growth factor.
Rubin JS, Bottaro DP, Chedid M, Miki T, Ron D, Cheon G, Taylor WG, Fortney E, Sakata H, Finch PW, et al. Rubin JS, et al. Cell Biol Int. 1995 May;19(5):399-411. doi: 10.1006/cbir.1995.1085. Cell Biol Int. 1995. PMID: 7640656 Review.
Cited by
- The effects of TGF-alpha, IL-1beta and PDGF on fibroblast adhesion to ECM-derived matrix and KGF gene expression.
Wang X, Waldeck H, Kao WJ. Wang X, et al. Biomaterials. 2010 Mar;31(9):2542-8. doi: 10.1016/j.biomaterials.2009.12.018. Epub 2009 Dec 29. Biomaterials. 2010. PMID: 20036421 Free PMC article. - Analysis of the cellular basis of keratinocyte growth factor overexpression in inflammatory bowel disease.
Finch PW, Cheng AL. Finch PW, et al. Gut. 1999 Dec;45(6):848-55. doi: 10.1136/gut.45.6.848. Gut. 1999. PMID: 10562583 Free PMC article. - Modulation of the keratinocyte-fibroblast paracrine relationship with gelatin-based semi-interpenetrating networks containing bioactive factors for wound repair.
Bader RA, Kao WJ. Bader RA, et al. J Biomater Sci Polym Ed. 2009;20(7-8):1005-30. doi: 10.1163/156856209X444402. J Biomater Sci Polym Ed. 2009. PMID: 19454166 Free PMC article. - Myofibroblast keratinocyte growth factor reduces tight junctional integrity and increases claudin-2 levels in polarized Caco-2 cells.
Kim TI, Poulin EJ, Blask E, Bukhalid R, Whitehead RH, Franklin JL, Coffey RJ. Kim TI, et al. Growth Factors. 2012 Oct;30(5):320-32. doi: 10.3109/08977194.2012.717076. Epub 2012 Sep 5. Growth Factors. 2012. PMID: 22946653 Free PMC article. - Oral mucositis induced by anticancer treatments: physiopathology and treatments.
Lionel D, Christophe L, Marc A, Jean-Luc C. Lionel D, et al. Ther Clin Risk Manag. 2006 Jun;2(2):159-68. doi: 10.2147/tcrm.2006.2.2.159. Ther Clin Risk Manag. 2006. PMID: 18360589 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources